Home Nucleus Pharmaceuticals U.K. Travel Vaccine Market to 2032

U.K. Travel Vaccine Market to 2032

Overview

The U.K. Travel Vaccine Market is expected to reach a 490.47 USD Million by 2032 and is projected to grow at a CAGR of 11.57% from 2025 to 2032.

Revenue, 2024 (USD Million)
245.86
Forecast, 2032 (USD Million)
490.47
CAGR, 2024 - 2032
11.57%
Report Coverage
U.K.

U.K. Travel Vaccine Market 2018-2032 USD Million

U.K. Travel Vaccine Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 245.86 USD Million
  • Projected Market Size (2032): 490.47 USD Million
  • CAGR (2025-2032): 11.57%

Key Findings of U.K. Travel Vaccine Market

  • The U.K. Travel Vaccine Market was valued at 245.86 USD Million in 2024.
  • The U.K. Travel Vaccine Market is likely to grow at a CAGR of 11.57% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 202.25 USD Million
  • The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 18.12% during the forecast period from 2024 to 2032.

U.K. Travel Vaccine Market Scope

U.K. Travel Vaccine Market Segmentation & Scope
Distribution Channel
  • B2C
  • B2B
Age Group
  • Above 50 Years
  • Less than 20 Years
  • 20-50 Years
Patient Type
  • Geriatric
  • Pediatric
  • Adult
Gender
  • Female
  • Male
Route of Administration
  • Oral
  • Injectable
Disease
  • COVID-19
  • Others
  • Polio
  • Malaria
  • Tick-Borne Encephalitis
  • Measles and Mumps
  • DPT
  • Rabies
  • Yellow Fever
  • Meningococcal Meningitis
  • Japanese Encephalitis
  • Influenza
  • Varicella
  • Cholera
  • Hepatitis
  • Typhoid
Category
  • Required Vaccine
  • Routine Vaccine
  • Recommended Vaccine
Type
  • Viral Vector Vaccines
  • DNA Vaccines
  • Toxoid Vaccines
  • Live-Attenuated Vaccines
  • Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
  • Inactivated Vaccines
Composition
  • Mono Vaccines
  • Combination Vaccines

U.K. Travel Vaccine Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 245.86 USD Million
Market Value in 2032 490.47 USD Million
CAGR (2025-2032) 11.57%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Disease,Category,Type,Composition

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 245.86 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 245.86 USD Million in 2024.

Segments and Scope

  • U.K. Travel Vaccine Market to 2032, By Distribution Channel
    • B2B is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 191.69 USD Million in the year 2024.
    • B2B is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 11.72 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Age Group
    • 20-50 Years is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 125.60 USD Million in the year 2024.
    • 20-50 Years is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 12.00 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Patient Type
    • Adult is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 114.91 USD Million in the year 2024.
    • Adult is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 12.17 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Gender
    • Male is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 132.19 USD Million in the year 2024.
    • Male is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 11.78 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Route of Administration
    • Injectable is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 202.25 USD Million in the year 2024.
    • Injectable is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Disease
    • Typhoid is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 48.07 USD Million in the year 2024.
    • Typhoid is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 18.12 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Category
    • Recommended Vaccine is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 118.29 USD Million in the year 2024.
    • Recommended Vaccine is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 11.96 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Type
    • Inactivated Vaccines is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 74.24 USD Million in the year 2024.
    • Inactivated Vaccines is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 12.59 % in forecast period 2025-2032.
  • U.K. Travel Vaccine Market to 2032, By Composition
    • Combination Vaccines is the largest segment in U.K. Travel Vaccine Market to 2032 with a revenue of 170.91 USD Million in the year 2024.
    • Combination Vaccines is the Fastest growing segment in U.K. Travel Vaccine Market to 2032 with a Growth rate of 11.72 % in forecast period 2025-2032.

U.K. Travel Vaccine Market Company Share Analysis

 
Company Name Company Share Analysis
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Pfizer Inc.
Sanofi
GSK plc.
U.K. Travel Vaccine Market Company Share Analysis

U.K. Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Travel Vaccine Market Company Profiling

U.K. Travel Vaccine Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.K. Travel Vaccine Market is segmented based on Segmentation Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Disease,Category,Type,Composition.
U.K. Travel Vaccine Market was valued at USD 245.86(Revenue in USD Million) in 2022.
U.K. Travel Vaccine Market is projected to grow at a CAGR of 11.57% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the U.K. Travel Vaccine Market, holding a largest market share of 202.25 USD Million in 2024

U.K. Travel Vaccine Market Scope

U.K. Travel Vaccine Market Segmentation & Scope
Distribution Channel
  • B2C
  • B2B
Age Group
  • Above 50 Years
  • Less than 20 Years
  • 20-50 Years
Patient Type
  • Geriatric
  • Pediatric
  • Adult
Gender
  • Female
  • Male
Route of Administration
  • Oral
  • Injectable
Disease
  • COVID-19
  • Others
  • Polio
  • Malaria
  • Tick-Borne Encephalitis
  • Measles and Mumps
  • DPT
  • Rabies
  • Yellow Fever
  • Meningococcal Meningitis
  • Japanese Encephalitis
  • Influenza
  • Varicella
  • Cholera
  • Hepatitis
  • Typhoid
Category
  • Required Vaccine
  • Routine Vaccine
  • Recommended Vaccine
Type
  • Viral Vector Vaccines
  • DNA Vaccines
  • Toxoid Vaccines
  • Live-Attenuated Vaccines
  • Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
  • Inactivated Vaccines
Composition
  • Mono Vaccines
  • Combination Vaccines
Frequently Asked Questions
The U.K. Travel Vaccine Market is segmented based on Segmentation Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Disease,Category,Type,Composition.
U.K. Travel Vaccine Market was valued at USD 245.86(Revenue in USD Million) in 2022.
U.K. Travel Vaccine Market is projected to grow at a CAGR of 11.57% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Travel Vaccine Market for final year is USD 490.47 (USD Million).

U.K. Travel Vaccine Market Company Profiling

U.K. Travel Vaccine Market Company Profiling
Frequently Asked Questions
The U.K. Travel Vaccine Market is segmented based on Segmentation Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Disease,Category,Type,Composition.
U.K. Travel Vaccine Market was valued at USD 245.86(Revenue in USD Million) in 2022.
U.K. Travel Vaccine Market is projected to grow at a CAGR of 11.57% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Travel Vaccine Market for final year is USD 490.47 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES